NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR STIMULATING PRIMARY MYELINATION Russian patent published in 2022 - IPC A23L33/115 A23L33/16 A23L33/15 

FIELD: food industry.

SUBSTANCE: invention relates to nutritional compositions for use in order to prevent, reduce the risk or mitigate a suboptimal trajectory of de novo myelination in a subject fed with a mixture. The use of an artificial nutrient composition containing phospholipid – sphingomyelin in the amount exceeding 300 mg/kg of the dry weight of the composition is proposed to prevent, reduce the risk or mitigate a suboptimal trajectory of de novo myelination in an infant or a child fed with a mixture. The trajectory of de novo myelination is suboptimal, when the distance between any equivalent and/or identical measurement points of an infant trajectory and a trajectory achieved in infants who are exclusively breastfed during their first (3) months of life exceeds 50%. The artificial nutritional composition contains sphingomyelin – not less than 300 mg/kg, folic acid – not less than 100 mcg/kg, vitamin B12 – at least 5 mcg/100 g, iron – at least 5 mg/100 g, a fatty acid compound, which is docosahexaenoic acid from 60 to 350 mg/100 g, arachidonic acid from 60 to 350 mg/100, where all weights relate to the dry weight of the composition. The composition is a composition selected from a group consisting of: infant formula, milk for children from 1 to 3 years old, a composition for infants intended for addition or dilution with human breast milk, and a food product intended for consumption by an infant and/or a child either separately or in combination with human breast milk. An infant is an infant under the age of 12 months, and a child is a person aged from 1 year to 18 years.

EFFECT: invention makes it possible to optimize the amount/degree of myelination in the subject.

9 cl, 66 dwg, 16 tbl, 8 ex